|
W. Gerald
Newmin
Anthony Altig
Stephen M. Chang
Thomas A. Page
Edward Sigmnond
|

|

|
|
W. Gerald Newmin, Chairman of the Board and Acting
Chief Financial Officer
(See Executive Profile)
|
|

|
|
Anthony Altig, Director
Mr. Anthony Altig was
appointed to MultiCell’s Board of Directors in September 2005. Mr. Altig
has been senior vice president and CFO of Diversa Corporation
(DVSA-NASDAQ), a public biotechnology company, since December 2004. From
October 2002 to November 2004, Mr. Altig served as vice president and CFO
of Maxim Pharmaceuticals, a biopharmaceutical company. From 2000 to 2001,
Mr.
Altig
served as executive vice president and CFO for NBC Internet, an Internet
consumer media and ecommerce portal company. From 1998 to 2000, Mr. Altig
served as executive partner and chief accounting officer of USWeb
Corporation (acquired by Whitman-Hart), an Internet professional services
firm. Mr. Altig was also a biotechnology and technology client service
executive with PricewaterhouseCoopers LLC and KPMG LLC from 1982 to 1998.
He is a CPA and a graduate of the University of Hawaii.
|
|

|
|
Stephen M. Chang, Ph.D., Director
Dr.
Stephen Chang has served as a director of the Company since June 2004,
became president of the Company in February 2005, and was appointed chief
executive officer (CEO) in May 2006. Dr. Chang is also president of MCT
Rhode Island Corp. and Xenogenics Corporation, and president, chief financial
officer (CFO), treasurer, and director of MCTI, a partially-owned
subsidiary of the Company. Dr. Chang is president of CURES, a coalition
of patient advocates, biotechnology companies, pharmaceutical companies,
and venture capitalists dedicated to ensuring the safety, research, and
development of innovative life saving medications. Dr. Chang is also on
the Board of BIOCOM, San Diego’s
premier life sciences organization. Dr. Chang was chief science officer
(CSO) and vice president of Canji Inc./Schering Plough Research Institute
in San Diego
from 1998 to 2004. He earned his doctoral degree in biological chemistry,
molecular biology, and biochemistry from the University of California,
Irvine.
|
|

|
|
Thomas A. Page, Director
Mr. Thomas Page has served as
a director of MultiCell since September 2003. He is director emeritus and
former chairman of the Board and CEO of Enova Corporation and San Diego
Gas and Electric company (now part of Sempra Energy [SRE-NYSE]). Mr. Page
has been active in numerous industrial, community, and governmental
associations and has funded medical research. He is a director of the San
Diego Regional Economic Development Corporation, Community National Bank,
Sys Technologies (SYSAMEX), and is an advisory director of Sorrento
Ventures. Mr. Page earned a bachelor of science degree in civil
engineering, a master’s in industrial administration, and was awarded a
doctorate in management, all from Purdue University. He has been licensed
as an engineer and as a CPA. Mr. Page also serves on the University of
California Presidents Council on the National Laboratories.
|
|

|
|
Edward Sigmond, Director
Mr. Edward Sigmond has served
as a director of the Company since May 2000. He has been in sales,
marketing, and operations management for the past 20 years. Mr. Sigmond
served as president of Kestrel Development, a Texas-based real estate
development company from 1993 to 1998, when it was dissolved. He studied
marketing and chemistry at Duquesne University.
|
|